• Our Company

QuintilesIMS Delivers Integrated Information and Technology Solutions to Drive Healthcare Forward

Around the world healthcare stakeholders are working to improve real-world patient outcomes through treatment innovations, care provision and access to healthcare. For the information, technology and service solutions they need to drive new insights and approaches, they count on QuintilesIMS. With a global team of 50,000, we harness insights, commercial and scientific depth, and executional expertise to empower clients to achieve some of their most important goals: Improving clinical, scientific and commercial results. Realizing the full potential of innovations. And, ultimately, driving healthcare forward.

For more information please visit www.quintilesims.com.

Driving Healthcare Performance in Romania

Established in Bucharest in 1994, QuintilesIMS Romania has one of the most comprehensive offering portfolios in the region, with its solutions for the pharmaceutical industry encompassing prescription data and sell-out services.

In 2007, QuintilesIMS Romania made a significant investment to help clients gain a deeper understanding of patient dynamics and introduced prescription-based services. This enhancement enabled companies in Romania to identify patient populations that would benefit most from specific treatments and to capture true market potential.

Furthermore, by launching its sell-out offering QuintilesIMS Romania addressed the need to provide more accurate data for measuring a final drug consumption level. Clients can now monitor real domestic market trends unaffected by trade phenomena, such as parallel trade.

The size of the pharmaceutical market in Romania (retail and hospital) reached €2,574 million in 2012, increasing over 4% compared to the previous year. While the top therapy area is still Cardiovascular, in 2012 the key area with the highest contribution to the total market was Diagnostic Agents, with a more than 13% increase against 2011. 285 corporations currently operate on the Romanian pharmaceutical market, 10 accounting for 58% of the total market sales.